Blue Trust Inc. trimmed its stake in Integer Holdings Co. (NYSE:ITGR - Free Report) by 71.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,618 shares of the medical equipment provider's stock after selling 4,025 shares during the period. Blue Trust Inc.'s holdings in Integer were worth $210,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Guidance Capital Inc. bought a new stake in shares of Integer during the first quarter valued at approximately $500,000. Congress Wealth Management LLC DE raised its stake in shares of Integer by 7.6% in the 1st quarter. Congress Wealth Management LLC DE now owns 69,328 shares of the medical equipment provider's stock valued at $8,089,000 after buying an additional 4,873 shares in the last quarter. AlphaMark Advisors LLC bought a new position in shares of Integer during the 1st quarter worth about $359,000. Tributary Capital Management LLC boosted its position in shares of Integer by 1.2% during the 1st quarter. Tributary Capital Management LLC now owns 285,677 shares of the medical equipment provider's stock valued at $33,333,000 after acquiring an additional 3,513 shares in the last quarter. Finally, Azzad Asset Management Inc. ADV increased its stake in Integer by 7.9% in the first quarter. Azzad Asset Management Inc. ADV now owns 7,772 shares of the medical equipment provider's stock valued at $907,000 after acquiring an additional 566 shares during the period. Institutional investors own 99.29% of the company's stock.
Insider Buying and Selling
In other news, Director Jean M. Hobby sold 11,960 shares of the company's stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the transaction, the director now owns 2,280 shares of the company's stock, valued at $272,824.80. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 2.00% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of research analysts have commented on ITGR shares. Citigroup raised their price target on shares of Integer from $124.00 to $130.00 and gave the stock a "neutral" rating in a research note on Tuesday, October 1st. KeyCorp raised their target price on Integer from $139.00 to $144.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 15th. Oppenheimer initiated coverage on Integer in a research report on Tuesday, July 16th. They issued an "outperform" rating and a $135.00 price target on the stock. Benchmark lifted their price objective on Integer from $130.00 to $140.00 and gave the company a "buy" rating in a report on Monday, October 21st. Finally, Bank of America upped their target price on shares of Integer from $135.00 to $145.00 and gave the stock a "buy" rating in a report on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, Integer has a consensus rating of "Moderate Buy" and a consensus price target of $139.75.
Read Our Latest Research Report on ITGR
Integer Price Performance
Shares of NYSE:ITGR traded down $0.99 during midday trading on Friday, reaching $125.77. The company's stock had a trading volume of 187,373 shares, compared to its average volume of 235,292. The business's fifty day simple moving average is $127.58 and its 200-day simple moving average is $120.98. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96. Integer Holdings Co. has a fifty-two week low of $73.40 and a fifty-two week high of $133.53. The company has a market capitalization of $4.22 billion, a P/E ratio of 41.10, a P/E/G ratio of 1.80 and a beta of 1.08.
Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.07. Integer had a net margin of 6.31% and a return on equity of 11.48%. The firm had revenue of $431.42 million during the quarter, compared to analysts' expectations of $440.59 million. During the same quarter last year, the company posted $1.27 EPS. The company's quarterly revenue was up 8.7% compared to the same quarter last year. As a group, equities research analysts expect that Integer Holdings Co. will post 5.3 EPS for the current fiscal year.
Integer Company Profile
(
Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Featured Stories
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
